Grace Christensen, a research analyst with the Office, explained that cannabinoids might reduce the frequency of apneas by suppressing vagal nerve activity. This hypothesis is supported by animal studies where THC, the primary psychoactive component in cannabis, demonstrated a reduction in sleep apnea episodes. Preliminary human trials using synthetic THC compounds have also indicated improvements in sleep quality and a decrease in apnea occurrences.
In light of these findings, Minnesota’s Medical Cannabis Program approved the use of medical cannabis for treating OSA in 2018. The recent survey conducted by the Office of Cannabis Management is the largest of its kind, gathering data from patients who have incorporated medical cannabis into their treatment regimen for OSA. The results suggest that many patients experienced significant relief from their symptoms.
However, it’s important to note that while these findings are promising, they are not yet conclusive. The American Academy of Sleep Medicine (AASM) has advised caution, citing insufficient evidence regarding the long-term safety and efficacy of medical cannabis for OSA treatment. They recommend that patients consult with licensed medical providers at accredited sleep facilities to explore proven treatment options.
As research continues, medical professionals and patients alike are hopeful that further studies will provide more definitive answers on the role of medical cannabis in managing obstructive sleep apnea.
For more information, you can listen to the full MPR News segment here: Study finds medical cannabis provided relief for those with obstructive sleep apnea.
Dabbin-Dad Newsroom
If you liked this post, say thanks by sharing it
